rs113671330

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017890.5(VPS13B):​c.9424A>G​(p.Ser3142Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00768 in 1,382,896 control chromosomes in the GnomAD database, including 104 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S3142N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0069 ( 6 hom., cov: 21)
Exomes 𝑓: 0.0077 ( 98 hom. )

Consequence

VPS13B
NM_017890.5 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.81

Publications

7 publications found
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
VPS13B Gene-Disease associations (from GenCC):
  • Cohen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035758317).
BP6
Variant 8-99832387-A-G is Benign according to our data. Variant chr8-99832387-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00689 (694/100794) while in subpopulation SAS AF = 0.0257 (91/3534). AF 95% confidence interval is 0.0215. There are 6 homozygotes in GnomAd4. There are 358 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS13BNM_017890.5 linkc.9424A>G p.Ser3142Gly missense_variant Exon 52 of 62 ENST00000358544.7 NP_060360.3
VPS13BNM_152564.5 linkc.9349A>G p.Ser3117Gly missense_variant Exon 52 of 62 ENST00000357162.7 NP_689777.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS13BENST00000358544.7 linkc.9424A>G p.Ser3142Gly missense_variant Exon 52 of 62 1 NM_017890.5 ENSP00000351346.2
VPS13BENST00000357162.7 linkc.9349A>G p.Ser3117Gly missense_variant Exon 52 of 62 1 NM_152564.5 ENSP00000349685.2

Frequencies

GnomAD3 genomes
AF:
0.00689
AC:
694
AN:
100764
Hom.:
6
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00312
Gnomad ASJ
AF:
0.0255
Gnomad EAS
AF:
0.000279
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.00641
Gnomad MID
AF:
0.0274
Gnomad NFE
AF:
0.00841
Gnomad OTH
AF:
0.00972
GnomAD2 exomes
AF:
0.00931
AC:
1368
AN:
146868
AF XY:
0.0112
show subpopulations
Gnomad AFR exome
AF:
0.000783
Gnomad AMR exome
AF:
0.00220
Gnomad ASJ exome
AF:
0.0206
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00370
Gnomad NFE exome
AF:
0.00782
Gnomad OTH exome
AF:
0.00942
GnomAD4 exome
AF:
0.00775
AC:
9931
AN:
1282102
Hom.:
98
Cov.:
59
AF XY:
0.00849
AC XY:
5369
AN XY:
632488
show subpopulations
African (AFR)
AF:
0.00172
AC:
47
AN:
27286
American (AMR)
AF:
0.00251
AC:
76
AN:
30248
Ashkenazi Jewish (ASJ)
AF:
0.0206
AC:
451
AN:
21892
East Asian (EAS)
AF:
0.0000641
AC:
2
AN:
31202
South Asian (SAS)
AF:
0.0259
AC:
1930
AN:
74396
European-Finnish (FIN)
AF:
0.00380
AC:
154
AN:
40476
Middle Eastern (MID)
AF:
0.0320
AC:
133
AN:
4154
European-Non Finnish (NFE)
AF:
0.00668
AC:
6683
AN:
1001008
Other (OTH)
AF:
0.00885
AC:
455
AN:
51440
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
460
920
1379
1839
2299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00689
AC:
694
AN:
100794
Hom.:
6
Cov.:
21
AF XY:
0.00760
AC XY:
358
AN XY:
47128
show subpopulations
African (AFR)
AF:
0.00125
AC:
31
AN:
24816
American (AMR)
AF:
0.00312
AC:
26
AN:
8344
Ashkenazi Jewish (ASJ)
AF:
0.0255
AC:
68
AN:
2664
East Asian (EAS)
AF:
0.000279
AC:
1
AN:
3588
South Asian (SAS)
AF:
0.0257
AC:
91
AN:
3534
European-Finnish (FIN)
AF:
0.00641
AC:
28
AN:
4370
Middle Eastern (MID)
AF:
0.0303
AC:
4
AN:
132
European-Non Finnish (NFE)
AF:
0.00841
AC:
432
AN:
51346
Other (OTH)
AF:
0.00964
AC:
13
AN:
1348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00675
Hom.:
15
Bravo
AF:
0.00413
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00629
AC:
54
ExAC
AF:
0.00620
AC:
737

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16648375)

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Cohen syndrome Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 18, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 30, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:2
Jan 17, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 02, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Sep 22, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.0
.;T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.011
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.62
T;T
MetaRNN
Benign
0.0036
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.0
.;L
PhyloP100
2.8
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.093
Sift
Benign
0.29
T;T
Sift4G
Benign
0.23
T;T
Vest4
0.28
ClinPred
0.023
T
GERP RS
4.4
Varity_R
0.16
gMVP
0.21
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113671330; hg19: chr8-100844615; COSMIC: COSV62142011; API